EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Quercetin Enhances the Antitumor Effect of Lenvatinib on Hepatocellular Carcinoma Cells

Jian Li, Qinghua Yin, Kai Liu, Xu Chen, Yang Zhou

Frontiers in Bioscience-Landmark · 2026-03-31 · 31 (4)

DOI: 10.31083/fbl47715 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, published online on 2026-03-31. Written by Jian Li and 4 co-authors. Institution: Department of General Surgery, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, 410005 Changsha, Hunan, Chin…. Major MEDLINE topics: Quercetin, Carcinoma, Hepatocellular, Liver Neoplasms, Phenylurea Compounds. 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: Research Project of Hunan Provincial Health Commission.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Molecular targeted therapies play a crucial role in the management of hepatocellular carcinoma (HCC). Lenvatinib is a standard targeted agent for advanced HCC, while quercetin has emerged as a promising natural compound with anti-HCC potential. This study investigates the combined effect of quercetin and lenvatinib on HCC.

Methods

The human HCC cell line Huh7 and a nude mouse subcutaneous xenograft model were utilized. We evaluated cell proliferation, clonogenicity, invasion, migration, and apoptosis through Cell Counting Kit-8 (CCK-8), clonogenic, Transwell, and flow cytometry assays, respectively. Network pharmacology analysis was performed identify common targets. The protein expression levels of B-cell lymphoma 2 (Bcl-2), Bcl-2 associated X-protein (Bax), E-cadherin, N-cadherin, and protein tyrosine kinase 2 (PTK2) were assessed by Western blotting. In vivo experiments were conducted to validate the anti-tumor efficacy of the combination treatment.

Results

The combination of quercetin and lenvatinib significantly enhanced inhibition of Huh7 cell proliferation, colony formation, invasion, and migration (p < 0.01) and promoted apoptosis (p < 0.01) compared to individual treatments. Mechanistically, the combination treatment decreased the expression of Bcl-2 and N-cadherin while upregulating Bax and E-cadherin. PTK2 was identified as a key shared target, and the combination most effectively suppressed its protein expression. In vivo, the combination group demonstrated a higher tumor inhibition rate (p < 0.01) and a Combination Index (CDI) of 0.753.

Conclusion

Quercetin significantly enhances the anti-tumor efficacy of lenvatinib, likely through synergistic inhibition of PTK2 expression.

Subjects

MeSH terms (MEDLINE)

QuercetinCarcinoma, HepatocellularLiver NeoplasmsPhenylurea CompoundsQuinolinesAntineoplastic AgentsHumansAnimalsCell ProliferationMiceCell Line, TumorApoptosisMice, NudeXenograft Model Antitumor AssaysCell MovementDrug Synergism

Author keywords

PTK2carcinomahepatocellularlenvatinibquercetin

Substances

lenvatinibQuercetinPhenylurea CompoundsQuinolinesAntineoplastic Agents

Authors and institutions

  • Department of General Surgery, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, 410005 Changsha, Hunan, China.
  • Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, 410005 Changsha, Hunan, China.

Funding

  • Research Project of Hunan Provincial Health Commission

Cite

APA

Li, J., Yin, Q., Liu, K., Chen, X., & Zhou, Y. (2026). Quercetin Enhances the Antitumor Effect of Lenvatinib on Hepatocellular Carcinoma Cells. Frontiers in Bioscience-Landmark, 31(4). https://doi.org/10.31083/fbl47715

Vancouver

Li J, Yin Q, Liu K, Chen X, Zhou Y. Quercetin Enhances the Antitumor Effect of Lenvatinib on Hepatocellular Carcinoma Cells. Frontiers in Bioscience-Landmark. 2026;31(4). doi:10.31083/fbl47715

BibTeX
@article{Li2026,
  author = {Li, Jian and Yin, Qinghua and Liu, Kai and Chen, Xu and Zhou, Yang},
  title = {Quercetin Enhances the Antitumor Effect of Lenvatinib on Hepatocellular Carcinoma Cells},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {4},
  doi = {10.31083/fbl47715}
}
Start for free →